Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U7 small nuclear 40 pseudogene (RNU7-40P) is classified as a pseudogene corresponding to U7 small nuclear RNA, located on human chromosome 12[7][1]. U7 snRNA itself is a functional non-coding RNA component of the U7 small nuclear ribonucleoprotein complex (U7 snRNP) that is essential for 3' end processing of replication-dependent histone pre-mRNAs[2][3]. However, RNU7-40P is a non-functional genomic fragment, not transcribed or translated into a functional product, and is not involved in canonical biological pathways or disease mechanisms[1][4][7][8]. Consequently, it is not considered a therapeutic target, biomarker, or druggable entity. Key details: - As a **pseudogene**, RNU7-40P does not encode a functional RNA or protein[1]. - There is no evidence linking RNU7-40P to any biological functions, disease roles, or known interactions with drugs. - U7 snRNA's functional versions are vital for histone mRNA maturation, but the RNU7-40P pseudogene is an inactive genomic element[2][3][4]. - The presence of “pseudogene” in the name and databases (such as NCBI, GeneCards, HGNC) indicates it is not a valid therapeutic target[1][7][8]. - Its aliases reflect standard gene and pseudogene nomenclature, but there are no functional or therapeutic implications. Thus, there is something incorrect from a drug discovery perspective: RNU7-40P is not a valid target due to its classification as a pseudogene and lack of biological activity or therapeutic implication[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U7 small nuclear 40 pseudogene (RNU7-40P).